3Suppliers
5Customers
2Debt Items
13Related Chains

Source-Backed Evidence Depth

Avenue Therapeutics, Inc. (ATXI) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

10Total relationships
4Distinct source URLs
4High confidence
0.786Average confidence
2026-10-29Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Avenue Therapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
DUKE-UNIVERSITY DUKE-UNIVERSITY 92% Under the License Agreement, the Company agreed to make an upfront payment and reimburse certain patent expenses to Duke
FBIO Fortress Biotech, Inc. 72% Reciprocal relationship from FBIO graph: Reciprocal relationship from ATXI graph: Reciprocal relationship from FBIO graph: Reciprocal relationship from ATXI graph: Reciprocal relationship from FBIO g…
FBIOP FBIOP 72% Reciprocal relationship from FBIOP graph: Reciprocal relationship from ATXI graph: Reciprocal relationship from FBIOP graph: Reciprocal relationship from ATXI graph: Reciprocal relationship from FBIO…

Avenue Therapeutics, Inc. Customers

TickerNameConfidenceEvidence
ANNJI ANNJI 92% Under the Termination and Transfer Agreement, AnnJi agreed to pay the Company $ 1.6 million (net of withholding taxes), which was received in 2025.
FBIO Fortress Biotech, Inc. 72% Reciprocal relationship from FBIO graph: Reciprocal relationship from ATXI graph: Reciprocal relationship from FBIO graph: Reciprocal relationship from ATXI graph: Reciprocal relationship from FBIO g…
FBIOP FBIOP 72% Reciprocal relationship from FBIOP graph: Reciprocal relationship from ATXI graph: product candidates and will rely on third parties to manufacture any products for which we receive regulatory approv…
FBIOP FBIOP 72% product candidates and will rely on third parties to manufacture any products for which we receive regulatory approval and their failure to produce them in the volumes that we require on a timely bas…
CO-LLC CO-LLC 62% rs, and smaller reporting companies are permitted to delay adoption of certain recent accounting. Basis of Presentation and Principles of Consolidation The Company’s consolidated financial statements…

Avenue Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
ATXI-DEBT-7963 Warrants outstanding: 545454 90% xbrl warrant detail from xbrl 2026-03-31.
ATXI-DEBT-7964 Xbrl Convertible 90% xbrl convertible detail from xbrl 2018-12-31.

Avenue Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Avenue Therapeutics, Inc..

Avenue Therapeutics, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Avenue Therapeutics, Inc..

Avenue Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
FBIOP Fortress Biotech, Inc. 100.00 1 ['customer', 'supplier']
FBIO Fortress Biotech, Inc. 100.00 1 ['customer', 'supplier']
ANNJI ANNJI 63.48 1 ['receiving']
ERNA Ernexa Therapeutics Inc. 50.00 2
AXSM Axsome Therapeutics, Inc. 50.00 2
RDY Dr. Reddy's Laboratories Limited 50.00 2
LLY Eli Lilly and Company 50.00 2
MBIO Mustang Bio, Inc. 50.00 2
OCSL Oaktree Specialty Lending Corporation 50.00 2
XYF X Financial 50.00 2
TGTX TG Therapeutics, Inc. 50.00 2
AZN AstraZeneca PLC 50.00 2
DERM Journey Medical Corporation 50.00 2
🔐
ATXI
Unlock ATXI Supply Chain Data
Verified relationships include:
DUKE-UNIVERSITYDUKE-UNIVERSITYSupplier92%
FBIOFortress Biotech, Inc.Supplier72%
ANNJIANNJICustomer92%
FBIOFortress Biotech, Inc.Customer72%
+6 more relationships locked
Subscribe, View plans →